BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrea L, Pugliese G, Muscogiuri G, Laudisio D, Colao A, Savastano S. New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists. Minerva Endocrinol 2020;45:127-37. [PMID: 32643356 DOI: 10.23736/S0391-1977.20.03179-X] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Verde L, Dalamaga M, Capó X, Annunziata G, Hassapidou M, Docimo A, Savastano S, Colao A, Muscogiuri G, Barrea L. The Antioxidant Potential of the Mediterranean Diet as a Predictor of Weight Loss after a Very Low-Calorie Ketogenic Diet (VLCKD) in Women with Overweight and Obesity. Antioxidants (Basel) 2022;12. [PMID: 36670880 DOI: 10.3390/antiox12010018] [Reference Citation Analysis]
2 Timmermans M, Topal B, Sanches EE, DE Jongh FW, Cagiltay E, Celik A, Ribeiro R, Parmar C, Ugale S, Proczko M, Stepaniak PS, Buise MP, Severin R, Pouwels S. The effects of glucagon like peptide-1 (GLP-1) on cardiac remodeling: exploring the role of medication and physiological modulation after metabolic surgery. Minerva Endocrinol (Torino) 2022;47:449-59. [PMID: 33759444 DOI: 10.23736/S2724-6507.21.03296-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cantone MC, Gaudenzi G, Carra S, Saronni D, Dicitore A. Obesity and GEP-NET: which to hit first? Minerva Med 2022;113:913-5. [PMID: 36695409 DOI: 10.23736/S0026-4806.22.08314-8] [Reference Citation Analysis]
4 El Ghoch M, Rossi AP, Verde L, Barrea L, Muscogiuri G, Savastano S, Colao A, on behalf of the Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) group. Understanding sarcopenic obesity in young adults in clinical practice: a review of three unsolved questions. Panminerva Med 2022;64. [DOI: 10.23736/s0031-0808.22.04784-x] [Reference Citation Analysis]
5 Song E, Shin NR, Jeon S, Nam Y, Kim H. Impact of the herbal medicine, Ephedra sinica stapf, on gut microbiota and body weight in a diet-induced obesity model. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1042833] [Reference Citation Analysis]
6 Ren G, Hwang PTJ, Millican R, Shin J, Brott BC, van Groen T, Powell CM, Bhatnagar S, Young ME, Jun HW, Kim JA. Subcutaneous Administration of a Nitric Oxide-Releasing Nanomatrix Gel Ameliorates Obesity and Insulin Resistance in High-Fat Diet-Induced Obese Mice. ACS Appl Mater Interfaces 2022;14:19104-15. [PMID: 35467831 DOI: 10.1021/acsami.1c24113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pelusi C. The Effects of the New Therapeutic Treatments for Diabetes Mellitus on the Male Reproductive Axis. Front Endocrinol 2022;13:821113. [DOI: 10.3389/fendo.2022.821113] [Reference Citation Analysis]
8 Barrea L, Vetrani C, Fintini D, de Alteriis G, Panfili FM, Bocchini S, Verde L, Colao A, Savastano S, Muscogiuri G. Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach. Curr Obes Rep 2022;11:263-76. [PMID: 36063285 DOI: 10.1007/s13679-022-00478-w] [Reference Citation Analysis]
9 Ivanova S, Delattre C, Karcheva-Bahchevanska D, Benbasat N, Nalbantova V, Ivanov K. Plant-Based Diet as a Strategy for Weight Control. Foods 2021;10:3052. [PMID: 34945602 DOI: 10.3390/foods10123052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Barrea L, Vetrani C, Caprio M, El Ghoch M, Frias-Toral E, Mehta RJ, Mendez V, Moriconi E, Paschou SA, Pazderska A, Savastano S, Colao A, Muscogiuri G. Nutritional management of type 2 diabetes in subjects with obesity: an international guideline for clinical practice. Crit Rev Food Sci Nutr 2021;:1-13. [PMID: 34554038 DOI: 10.1080/10408398.2021.1980766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gorain B, Choudhury H, Sengupta P, Verma RK, Pandey M. Extrapolation from Clinical Trial to Practice: Current Pharmacotherapy on Obesity. Obesity and its Impact on Health 2021. [DOI: 10.1007/978-981-33-6408-0_10] [Reference Citation Analysis]
12 Barrea L, Frias-Toral E, Pugliese G, Garcia-Velasquez E, DE Los Angeles Carignano M, Savastano S, Colao A, Muscogiuri G. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol (Torino) 2021;46:177-92. [PMID: 33213116 DOI: 10.23736/S2724-6507.20.03299-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
13 Xie H, Yepuri N, Meng Q, Dhawan R, Leech CA, Chepurny OG, Holz GG, Cooney RN. Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation. Rev Endocr Metab Disord 2020;21:431-47. [PMID: 32851581 DOI: 10.1007/s11154-020-09584-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]